Annual report pursuant to Section 13 and 15(d)

Share-Based Compensation Plans (Tables)

v3.20.4
Share-Based Compensation Plans (Tables)
12 Months Ended
Nov. 01, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award Activity
The following tables summarize the activities related to the Company’s share-based equity and liability awards for the fiscal year ended November 1, 2020 and November 3, 2019:
Number of Weighted Average
Performance Share Units Shares Grant Date Fair Value
Outstanding at October 28, 2018 276,396  $ 3.38 
     Granted (a) (b) 377,833  $ 4.05 
     Forfeited (179,981) $ 3.61 
     Vested (97,262) $ 3.82 
Outstanding at November 3, 2019 376,986  $ 3.90 
     Forfeited (40,311) $ 3.38 
     Vested (127,013) $ 4.04 
Outstanding at November 1, 2020 209,662  $ 3.91 
(a) Includes the incremental issuance of shares related to the fiscal 2018 PSU grant.
(b) Includes the incremental shares for the first tranche of the fiscal 2019 PSU grant based on attainment of the fiscal 2019 EBITDA margin percentage goal that were issued upon vesting.

Number of Weighted Average
Restricted Stock Units Shares Grant Date Fair Value
Outstanding at October 28, 2018 582,831  $ 3.53 
     Granted 516,968  $ 4.11 
     Forfeited (236,035) $ 3.73 
     Vested (196,682) $ 3.75 
Outstanding at November 3, 2019 667,082  $ 3.86 
     Granted 625,909  $ 1.09 
     Forfeited (4,387) $ 3.79 
     Vested (312,424) $ 3.90 
Outstanding at November 1, 2020 976,180  $ 2.08 
Stock Options Number of
shares
Weighted
average
exercise price
Weighted average
contractual life
(in years)
Aggregate
Intrinsic
Value
(in thousands)
Outstanding at October 28, 2018 1,600,040  $ 5.25  7.27 $ — 
     Exercised (200,000) $ 4.35  —  $ — 
Forfeited (335,972) $ 5.42  —  $ — 
     Expired (460,584) $ 5.36  —  $ — 
Outstanding at November 3, 2019 603,484  $ 6.28  6.81 $ — 
Forfeited (60,615) $ 8.22  —  $ — 
    Expired (210,925) $ 6.59  —  $ — 
Outstanding at November 1, 2020 331,944  $ 5.73  6.22
Unvested at November 1, 2020 44,394  $ 4.10  7.09
Exercisable at November 1, 2020 287,550  $ 5.98  6.09